Skip to content

The efficacy of hydrogen eye drop for the ischemia-reperfusion injury of retinal artery occlusion

The efficacy of hydrogen eye drop for the ischemia-reperfusion injury of retinal artery occlusion - The efficacy of hydrogen eye drop for retinal artery occlusion

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000015528
Enrollment
10
Registered
2014-10-27
Start date
2014-10-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinal artery occlusion

Interventions

Sponsors

Nippon Medical School Ophthalmology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with retinal artery occlusion.

Exclusion criteria

Exclusion criteria: Patients without thrombolytic therapy.

Design outcomes

Primary

MeasureTime frame
visual acuity

Secondary

MeasureTime frame
inner retinal layer, retinal electogram

Countries

Japan

Contacts

Public ContactTomonaga Takase

Nippon Medical School Hospital IRB

clinicaltrial@nms.ac.jp03-3822-2131

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026